K
Originally published by Kenyanstop
February 11, 2026
2h ago
KEMRI to Develop Vaccine to Protect Newborns

If successful, KEMRI’s maternal vaccine could position Kenya as a leader in neonatal health innovation, offering new hope for thousands of vulnerable newborns across Africa...
✨ Key Highlights
The Kenya Medical Research Institute (KEMRI) is pioneering research to develop a maternal vaccine aimed at protecting newborns from deadly hospital-acquired infections, particularly targeting Klebsiella pneumoniae, a highly antibiotic-resistant bacterium.
- KEMRI conducted a study between 2020 and 2023, revealing a worrying increase in neonatal infections due to issues like overcrowded wards and poor sanitation.
- The vaccine strategy involves vaccinating mothers during pregnancy so they can pass protective antibodies to their newborns, especially crucial for vulnerable babies in developing countries like Kenya.
- This initiative could significantly reduce infant mortality caused by infections and position Kenya as a leader in neonatal health innovation.
Continue Reading
Read the complete article from Kenyans
Advertisement
Related News
Advertisement




